Photo Release: Zuellig Pharma announces investment in HBC

Zuellig Pharma, the region's leading healthcare services provider, signed an agreement to invest in Health Benefit Consultants Company (HBC) through its Malaysian subsidiary – MiCare Sdn Bhd. HBC is a leading third party administrator in Thailand providing medical claims administration and related consulting and advisory services to corporates and insurance companies. This partnership will focus on growing HBC in Thailand and expanding the services and health benefits it offers to Thai people. Meanwhile, HBC will have access to MiCare's global network, providing it with greater business expansion opportunity.
Photo shows: Mr. Moses Hee, Zuellig Pharma Vice President Integrated Solutions (left), andMr. Permsak Natenuj, Managing Director of Health Benefit Consultants Co., Ltd. (right) exchanging signed agreement as Zuellig Pharma made significant investment in HBC. Mr. Yves Hermes, Zuellig Pharma Chief Executive, Thailand & Indochina, Taiwan (middle) joined as a witness.

CLINIXIR, A LEADING CONTRACT RESEARCH ORGANIZATION IN THAILAND, ANNOUNCES NEW CEO, DR. PUCHONG PADUNGSUTT

Dr. Puchong Padungsutt has assumed the role of CEO at Clinixir (www.clinixir.com ), Thailand's leading contract research organization (CRO). Dr. Padungsutt brings to Clinixir more than two decades of leadership in the medical and pharmaceutical industries. His career has spanned high-level positions, including Vice President of Medical Affairs and Country Medical Director at Zuellig Pharma, where he led cross-functional teams and launched products in therapeutic areas such as Oncology, Women's

17 ตุลาคม 2567 09:03 น.

Zuellig Pharma Receives EcoVadis Platinum Medal in 2021 For Sustainability — Zuellig Pharma, a leading healthcare services provider in Asia, has been awar... ต.ค. 64

Government Pharmaceutical Organization Confirms Purchase of Five Million Doses of COVID-19 Vaccine Moderna — The COVID-19 Vaccine Moderna will be availab... ก.ค. 64

International Finance Corporation จับมือ Mitsui เตรียมลงทุน 60 ล้านดอลลาร์สหรัฐใน MiCare Health Technologies ที่สิงคโปร์ — การลงทุนเชิงกลยุทธ์เพื่อช่วยขยา... พ.ค. 64

International Finance Corporation and Mitsui to invest c.US$60 million in Singapore-based MiCare Health Technologies — Strategic investment to help expand... พ.ค. 64

Zuellig Pharma Clinches Ecovadis Gold Medal 2021 For Sustainability — Zuellig Pharma, a leading healthcare services provider in Asia has been awarded the ... เม.ย. 64

Zuellig Pharma คว้าเหรียญทอง Ecovadis ปี 2021 ด้านความยั่งยืน — Zuellig Pharma ผู้ให้บริการเฮลธ์แคร์ระดับชั้นนำในเอเชีย ได้รับรางวัล Gold Medal 2021 จากผู... เม.ย. 64

Zuellig Pharma launches blockchain-based eZTracker in Thailand to help consumers verify authorized aesthetics products in seconds — Zuellig Pharma, a lead... ก.พ. 64

Zuellig Pharma expands cold storage warehouse capacity across key markets in Asia in preparation for COVID-19 vaccine — Zuellig Pharma, a leading healthca... พ.ย. 63

Zuellig Pharma แต่งตั้ง จอห์น เกรแฮม ดำรงตำแหน่งซีอีโอคนใหม่ — Zuellig Pharma ผู้ให้บริการดูแลสุขภาพชั้นนำในเอเชีย ประกาศแต่งตั้งคุณจอห์น เกรแฮม ดำรงตำแหน... ก.ค. 63

Photo Release: Zuellig Pharma announces investment in HBC

ข่าวZuellig Pharma+o:genวันนี้

CLINIXIR, A LEADING CONTRACT RESEARCH ORGANIZATION IN THAILAND, ANNOUNCES NEW CEO, DR. PUCHONG PADUNGSUTT